amitriptyline has been researched along with Hepatocellular Carcinoma in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evason, KJ | 1 |
| Francisco, MT | 1 |
| Juric, V | 1 |
| Balakrishnan, S | 1 |
| Lopez Pazmino, Mdel P | 1 |
| Gordan, JD | 1 |
| Kakar, S | 1 |
| Spitsbergen, J | 1 |
| Goga, A | 1 |
| Stainier, DY | 1 |
| Cordero, MD | 1 |
| Sánchez-Alcázar, JA | 1 |
| Bautista-Ferrufino, MR | 1 |
| Carmona-López, MI | 1 |
| Illanes, M | 1 |
| Ríos, MJ | 1 |
| Garrido-Maraver, J | 1 |
| Alcudia, A | 1 |
| Navas, P | 1 |
| de Miguel, M | 1 |
2 other studies available for amitriptyline and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
Topics: Amitriptyline; Animals; Animals, Genetically Modified; Antidepressive Agents, Tricyclic; beta Cateni | 2015 |
Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs.
Topics: Amitriptyline; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Carcinoma, Non- | 2010 |